News articles about Biostar Pharmaceuticals (NASDAQ:BSPM) have been trending somewhat negative on Wednesday, according to Accern Sentiment. The research firm identifies negative and positive news coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Biostar Pharmaceuticals earned a news sentiment score of -0.05 on Accern’s scale. Accern also assigned news stories about the company an impact score of 48.4131474999246 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

Biostar Pharmaceuticals (NASDAQ:BSPM) traded down 2.1136% during mid-day trading on Wednesday, reaching $1.2921. The company’s stock had a trading volume of 684 shares. Biostar Pharmaceuticals has a one year low of $1.20 and a one year high of $7.06. The stock has a 50-day moving average price of $1.48 and a 200-day moving average price of $2.03. The company’s market capitalization is $3.44 million.

Separately, ValuEngine lowered Biostar Pharmaceuticals from a “hold” rating to a “sell” rating in a report on Friday, June 9th.

TRADEMARK VIOLATION WARNING: This news story was published by Daily Political and is owned by of Daily Political. If you are viewing this news story on another website, it was illegally stolen and republished in violation of US & international copyright laws. The legal version of this news story can be accessed at

Biostar Pharmaceuticals Company Profile

Biostar Pharmaceuticals, Inc (Biostar) is a holding company. The Company, through its subsidiary, Shaanxi Biostar Biotech, Ltd. (Shaanxi Biostar), and its variable interest entities (VIEs), Shaanxi Aoxing Pharmaceutical Co, Ltd. (Aoxing Pharmaceutical) and Shaanxi Weinan Huaren Pharmaceuticals Ltd. (Shaanxi Weinan), develops, manufactures and markets pharmaceutical products for various diseases and conditions in the People’s Republic of China (PRC or China).

Insider Buying and Selling by Quarter for Biostar Pharmaceuticals (NASDAQ:BSPM)

Receive News & Ratings for Biostar Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biostar Pharmaceuticals Inc and related companies with's FREE daily email newsletter.